Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs.
The present study has evaluated the protection conferred by a single subcutaneous dose of a modified vaccinia virus Ankara (MVA) vectored vaccine encoding the Rift Valley Fever virus (RVFV) glycoproteins Gn and Gc in lambs. Three groups of six to seven lambs were immunized as follows: one group rece...
Главные авторы: | Busquets, N, Lorenzo, G, López-Gil, E, Rivas, R, Solanes, D, Galindo-Cardiel, I, Abad, F, Rodríguez, F, Bensaid, A, Warimwe, G, Gilbert, S, Domingo, M, Brun, A |
---|---|
Формат: | Journal article |
Язык: | English |
Опубликовано: |
Elsevier
2014
|
Схожие документы
-
Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs
по: Busquets, N, и др.
Опубликовано: (2014) -
Evaluation of the protective potential of a recombinant modified vaccinia virus Ankara (MVA) encoding rift valley fever virus (RVFV) glycoproteins in lambs
по: Busquets, N, и др.
Опубликовано: (2011) -
Rift Valley fever: biology and epidemiology
по: Wright, D, и др.
Опубликовано: (2019) -
Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice.
по: Warimwe, G, и др.
Опубликовано: (2013) -
MVA Vectored Vaccines Encoding Rift Valley Fever Virus Glycoproteins Protect Mice against Lethal Challenge in the Absence of Neutralizing Antibody Responses
по: Elena López-Gil, и др.
Опубликовано: (2020-02-01)